Rigshospitalet in association with Herlev-Gentofte Hospital
and The Technical University of Denmark (DTU)
Your hospital to Go – Acute patients treated with
Intravenous Antibiotics at home without clinical staff being
What do we offer?
We want to enable patients to regain some control over
their lives even though they have a serious diagnosis and
are having acute treatment. Our ambition is to develop
new solutions that enable patients to take a part of the
The project scope is to find out how far down that road we
can go by combining a new service design with devices that
can monitor patients at a distance.
In 2015 Rigshospitalet launched a concept that enables
patients with acute leukemia to have treatment with high
intensive chemotherapy and intravenous antibiotics at
home without any clinical staff being present. This
concept is now implemented at the other DK hematology
Now we want to scale the IV AB part of this concept to
new and larger patient segments.
What differentiates us?
We have a proven concept with leukemia patients. This includes experience with design, implementation and
scaling. The clue to this is to let clinicians work directly with clinicians to ensure a full transferal of knowledge on
how to run Your Hospital to Go solutions including adapting to local requirements.
Patients’ gains are more time with family and friends and a possibility to keep up with many everyday routines. As
the number of days as an in-patient will be reduced substantially the clinic will be able to redirect resources to
patients more in need of in-patient facilities.
What do we look for at the Medico Bazar?
Insight on technology, process flow, monitoring, patients’ needs and financial back up.
Rigshospitalet: firstname.lastname@example.org (RH Innovation)
DTU: viggo.aaberg.kærn@dtu.dk (DTU Innovation and Sector Services)